Prosecution Insights
Last updated: April 19, 2026

Prestige Biopharma Pte. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17800405 NON-PROTEIN A PURIFICATION METHOD FOR ADALIMUMAB YOUTCHOM PENDIE, EMMANUEL LED 1647 Final Rejection Aug 17, 2022

Managing Prestige Biopharma Pte. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month